The roles of c-Jun NH2-terminal kinases (JNKs) in obesity and insulin resistance

Journal of Physiology

Volumn 594, Issue 2, 2016, Pages 267-279

  Pal, Martin ^a   Febbraio, Mark A ^a,b   Lancaster, Graeme I ^b  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

STRESS ACTIVATED PROTEIN KINASE;

ADENOHYPOPHYSIS; ADIPOCYTE; ARTICLE; DISEASE ASSOCIATION; ENZYME ACTIVATION; ENZYME MECHANISM; FATTY LIVER; HUMAN; HYPERGLYCEMIA; HYPOTHALAMUS; INFLAMMATION; INSULIN RESISTANCE; LIPID DIET; MACROPHAGE; METABOLIC REGULATION; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; ANIMAL; GENETICS; METABOLISM; SECOND MESSENGER;

ANIMALS; HUMANS; INSULIN RESISTANCE; JNK MITOGEN-ACTIVATED PROTEIN KINASES; OBESITY; SECOND MESSENGER SYSTEMS;

EID: 84956798877     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/JP271457     Document Type: Article

References (65)

1. 307. J Biol Chem 275, 9047-9054.
2. Ammendrup A, Maillard A, Nielsen K, Aabenhus Andersen N, Serup P, Dragsbaek Madsen O, Mandrup-Poulsen T & Bonny C (2000). The c-Jun amino-terminal kinase pathway is preferentially activated by interleukin-1 and controls apoptosis in differentiating pancreatic β-cells. Diabetes 49, 1468-1476.
3. Belgardt BF, Mauer J, Wunderlich FT, Ernst MB, Pal M, Spohn G, Bronneke HS, Brodesser S, Hampel B, Schauss AC & Bruning JC (2010). Hypothalamic and pituitary c-Jun N-terminal kinase 1 signaling coordinately regulates glucose metabolism. Proc Natl Acad Sci USA 107, 6028-6033.
4. Boden G, Duan X, Homko C, Molina EJ, Song W, Perez O, Cheung P & Merali S (2008). Increase in endoplasmic reticulum stress-related proteins and genes in adipose tissue of obese, insulin-resistant individuals. Diabetes 57, 2438-2444.
5. Cai D, Frantz JD, Tawa NE, Jr., Melendez PA, Oh BC, Lidov HG, Hasselgren PO, Frontera WR, Lee J, Glass DJ & Shoelson SE (2004). IKKβ/NF-κB activation causes severe muscle wasting in mice. Cell 119, 285-298.
6. Carvalho BM, Oliveira AG, Ueno M, Araujo TG, Guadagnini D, Carvalho-Filho MA, Geloneze B, Lima MM, Pareja JC, Carvalheira JB & Saad MJ (2013). Modulation of double-stranded RNA-activated protein kinase in insulin sensitive tissues of obese humans. Obesity 21, 2452-2457.
7. Chen L, Magliano DJ & Zimmet PZ (2012). The worldwide epidemiology of type 2 diabetes mellitus - present and future perspectives. Nat Rev Endocrinol 8, 228-236.
8. Chung J, Nguyen AK, Henstridge DC, Holmes AG, Chan MH, Mesa JL, Lancaster GI, Southgate RJ, Bruce CR, Duffy SJ, Horvath I, Mestril R, Watt MJ, Hooper PL, Kingwell BA, Vigh L, Hevener A & Febbraio MA (2008). HSP72 protects against obesity-induced insulin resistance. Proc Natl Acad Sci USA 105, 1739-1744.
9. Copps KD, Hancer NJ, Opare-Ado L, Qiu W, Walsh C & White MF (2010). Irs1 serine 307 promotes insulin sensitivity in mice. Cell Metab 11, 84-92.
10. Davis RJ (2000). Signal transduction by the JNK group of MAP kinases. Cell 103, 239-252.
11. Derijard B, Hibi M, Wu IH, Barrett T, Su B, Deng T, Karin M & Davis RJ (1994). JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76, 1025-1037.
12. Furuhashi M & Hotamisligil GS (2008). Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nature Rev Drug Discov 7, 489-503.
13. Galic S, Sachithanandan N, Kay TW & Steinberg GR (2014). Suppressor of cytokine signalling (SOCS) proteins as guardians of inflammatory responses critical for regulating insulin sensitivity. Biochem J 461, 177-188.
14. Glass CK & Olefsky JM (2012). Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metab 15, 635-645.
15. Gregor MF, Yang L, Fabbrini E, Mohammed BS, Eagon JC, Hotamisligil GS & Klein S (2009). Endoplasmic reticulum stress is reduced in tissues of obese subjects after weight loss. Diabetes 58, 693-700.
16. Han MS, Jung DY, Morel C, Lakhani SA, Kim JK, Flavell RA & Davis RJ (2013). JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation. Science 339, 218-222.
17. Henstridge DC, Bruce CR, Pang CP, Lancaster GI, Allen TL, Estevez E, Gardner T, Weir JM, Meikle PJ, Lam KS, Xu A, Fujii N, Goodyear LJ & Febbraio MA (2012). Skeletal muscle-specific overproduction of constitutively activated c-Jun N-terminal kinase (JNK) induces insulin resistance in mice. Diabetologia 55, 2769-2778.
18. Hibi M, Lin A, Smeal T, Minden A & Karin M (1993). Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev 7, 2135-2148.
19. Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, Maeda K, Karin M & Hotamisligil GS (2002). A central role for JNK in obesity and insulin resistance. Nature 420, 333-336.
20. Hoehn KL, Hohnen-Behrens C, Cederberg A, Wu LE, Turner N, Yuasa T, Ebina Y & James DE (2008). IRS1-independent defects define major nodes of insulin resistance. Cell Metab 7, 421-433.
21. Hotamisligil GS (2006). Inflammation and metabolic disorders. Nature 444, 860-867.
22. Hotamisligil GS, Arner P, Caro JF, Atkinson RL & Spiegelman BM (1995). Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest 95, 2409-2415.
23. Hotamisligil GS, Shargill NS & Spiegelman BM (1993). Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 259, 87-91.
24. Houstis N, Rosen ED & Lander ES (2006). Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 440, 944-948.
25. Kahn SE, Hull RL & Utzschneider KM (2006). Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444, 840-846.
26. Kotas ME & Medzhitov R (2015). Homeostasis, inflammation, and disease susceptibility. Cell 160, 816-827.
27. McNelis JC & Olefsky JM (2014). Macrophages, immunity, and metabolic disease. Immunity 41, 36-48.
28. Maedler K, Schulthess FT, Bielman C, Berney T, Bonny C, Prentki M, Donath MY & Roduit R (2008). Glucose and leptin induce apoptosis in human β-cells and impair glucose-stimulated insulin secretion through activation of c-Jun N-terminal kinases. FASEB J 22, 1905-1913.
29. 2-terminal kinase activity in insulin-secreting cells: evidence for cytoplasmic restriction. Diabetes 50, 2721-2728.
30. Martens K, Bottelbergs A & Baes M (2010). Ectopic recombination in the central and peripheral nervous system by aP2/FABP4-Cre mice: implications for metabolism research. FEBS Lett 584, 1054-1058.
31. Mullur R, Liu YY & Brent GA (2014). Thyroid hormone regulation of metabolism. Physiol Rev 94, 355-382.
32. Nakano H, Nakajima A, Sakon-Komazawa S, Piao JH, Xue X & Okumura K (2006). Reactive oxygen species mediate crosstalk between NF-κB and JNK. Cell Death Differ 13, 730-737.
33. Nakatani Y, Kaneto H, Kawamori D, Hatazaki M, Miyatsuka T, Matsuoka TA, Kajimoto Y, Matsuhisa M, Yamasaki Y & Hori M (2004). Modulation of the JNK pathway in liver affects insulin resistance status. J Biol Chem 279, 45803-45809.
34. + effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 15, 914-920.
35. Osborn O & Olefsky JM (2012). The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med 18, 363-374.
36. Ozcan U, Cao Q, Yilmaz E, Lee AH, Iwakoshi NN, Ozdelen E, Tuncman G, Gorgun C, Glimcher LH & Hotamisligil GS (2004). Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306, 457-461.
37. Pal M, Wunderlich CM, Spohn G, Bronneke HS, Schmidt-Supprian M & Wunderlich FT (2013). Alteration of JNK-1 signaling in skeletal muscle fails to affect glucose homeostasis and obesity-associated insulin resistance in mice. PLoS One 8, e54247.
38. Pedersen BK & Febbraio MA (2008). Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev 88, 1379-1406.
39. Perry RJ, Camporez JP, Kursawe R, Titchenell PM, Zhang D, Perry CJ, Jurczak MJ, Abudukadier A, Han MS, Zhang XM, Ruan HB, Yang X, Caprio S, Kaech SM, Sul HS, Birnbaum MJ, Davis RJ, Cline GW, Petersen KF & Shulman GI (2015). Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes. Cell 160, 745-758.
40. Rohl M, Pasparakis M, Baudler S, Baumgartl J, Gautam D, Huth M, De Lorenzi R, Krone W, Rajewsky K & Bruning JC (2004). Conditional disruption of IκB kinase 2 fails to prevent obesity-induced insulin resistance. J Clin Invest 113, 474-481.
41. Sabio G, Cavanagh-Kyros J, Barrett T, Jung DY, Ko HJ, Ong H, Morel C, Mora A, Reilly J, Kim JK & Davis RJ (2010a). Role of the hypothalamic-pituitary-thyroid axis in metabolic regulation by JNK1. Genes Dev 24, 256-264.
42. Sabio G, Cavanagh-Kyros J, Ko HJ, Jung DY, Gray S, Jun JY, Barrett T, Mora A, Kim JK & Davis RJ (2009). Prevention of steatosis by hepatic JNK1. Cell Metab 10, 491-498.
43. Sabio G, Das M, Mora A, Zhang Z, Jun JY, Ko HJ, Barrett T, Kim JK & Davis RJ (2008). A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science 322, 1539-1543.
44. Sabio G & Davis RJ (2014). TNF and MAP kinase signalling pathways. Semin Immunol 26, 237-245.
45. Sabio G, Kennedy NJ, Cavanagh-Kyros J, Jung DY, Ko HJ, Ong H, Barrett T, Kim JK & Davis RJ (2010b). Role of muscle c-Jun NH2-terminal kinase 1 in obesity-induced insulin resistance. Mol Cell Biol 30, 106-115.
46. Seki E, Brenner DA & Karin M (2012). A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches. Gastroenterology 143, 307-320.
47. Solinas G, Vilcu C, Neels JG, Bandyopadhyay GK, Luo JL, Naugler W, Grivennikov S, Wynshaw-Boris A, Scadeng M, Olefsky JM & Karin M (2007). JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. Cell Metab 6, 386-397.
48. Sourris KC, Lyons JG, de Courten MP, Dougherty SL, Henstridge DC, Cooper ME, Hage M, Dart A, Kingwell BA, Forbes JM & de Courten B (2009). c-Jun NH2-terminal kinase activity in subcutaneous adipose tissue but not nuclear factor-κB activity in peripheral blood mononuclear cells is an independent determinant of insulin resistance in healthy individuals. Diabetes 58, 1259-1265.
49. Subramanian SL, Hull RL, Zraika S, Aston-Mourney K, Udayasankar J & Kahn SE (2012). cJUN N-terminal kinase (JNK) activation mediates islet amyloid-induced β cell apoptosis in cultured human islet amyloid polypeptide transgenic mouse islets. Diabetologia 55, 166-174.
50. Talukdar S, Oh da Y, Bandyopadhyay G, Li D, Xu J, McNelis J, Lu M, Li P, Yan Q, Zhu Y, Ofrecio J, Lin M, Brenner MB & Olefsky JM (2012). Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase. Nat Med 18, 1407-1412.
51. Tsaousidou E, Paeger L, Belgardt BF, Pal M, Wunderlich CM, Bronneke H, Collienne U, Hampel B, Wunderlich FT, Schmidt-Supprian M, Kloppenburg P & Bruning JC (2014). Distinct roles for JNK and IKK activation in agouti-related peptide neurons in the development of obesity and insulin resistance. Cell Rep 9, 1495-1506.
52. Tuncman G, Hirosumi J, Solinas G, Chang L, Karin M & Hotamisligil GS (2006). Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance. Proc Natl Acad Sci USA 103, 10741-10746.
53. Urano F, Wang X, Bertolotti A, Zhang Y, Chung P, Harding HP & Ron D (2000). Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 287, 664-666.
54. Uysal KT, Wiesbrock SM, Marino MW & Hotamisligil GS (1997). Protection from obesity-induced insulin resistance in mice lacking TNF-α function. Nature 389, 610-614.
55. Vallerie SN, Furuhashi M, Fucho R & Hotamisligil GS (2008). A predominant role for parenchymal c-Jun amino terminal kinase (JNK) in the regulation of systemic insulin sensitivity. PLoS One 3, e3151.
56. Vernia S, Cavanagh-Kyros J, Barrett T, Jung DY, Kim JK & Davis RJ (2013). Diet-induced obesity mediated by the JNK/DIO2 signal transduction pathway. Genes Dev 27, 2345-2355.
57. Vernia S, Cavanagh-Kyros J, Garcia-Haro L, Sabio G, Barrett T, Jung DY, Kim JK, Xu J, Shulha HP, Garber M, Gao G & Davis RJ (2014). The PPARα-FGF21 hormone axis contributes to metabolic regulation by the hepatic JNK signaling pathway. Cell Metab 20, 512-525.
58. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL & Ferrante AW, Jr (2003). Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112, 1796-1808.
59. Wensveen FM, Jelencic V, Valentic S, Sestan M, Wensveen TT, Theurich S, Glasner A, Mendrila D, Stimac D, Wunderlich FT, Bruning JC, Mandelboim O & Polic B (2015). NK cells link obesity-induced adipose stress to inflammation and insulin resistance. Nat Immunol 16, 376-385.
60. Whitham M, Chan MH, Pal M, Matthews VB, Prelovsek O, Lunke S, El-Osta A, Broenneke H, Alber J, Bruning JC, Wunderlich FT, Lancaster GI & Febbraio MA (2012). Contraction-induced interleukin-6 gene transcription in skeletal muscle is regulated by c-Jun terminal kinase/activator protein-1. J Biol Chem 287, 10771-10779.
61. Winer DA, Winer S, Shen L, Wadia PP, Yantha J, Paltser G, Tsui H, Wu P, Davidson MG, Alonso MN, Leong HX, Glassford A, Caimol M, Kenkel JA, Tedder TF, McLaughlin T, Miklos DB, Dosch HM & Engleman EG (2011). B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat Med 17, 610-617.
62. Woodcock KJ, Kierdorf K, Pouchelon CA, Vivancos V, Dionne MS & Geissmann F (2015). Macrophage-derived upd3 cytokine causes impaired glucose homeostasis and reduced lifespan in Drosophila fed a lipid-rich diet. Immunity 42, 133-144.
63. Wunderlich FT, Strohle P, Konner AC, Gruber S, Tovar S, Bronneke HS, Juntti-Berggren L, Li LS, van Rooijen N, Libert C, Berggren PO & Bruning JC (2010). Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action. Cell Metab 12, 237-249.
64. Yamamoto H, Williams EG, Mouchiroud L, Canto C, Fan W, Downes M, Heligon C, Barish GD, Desvergne B, Evans RM, Schoonjans K & Auwerx J (2011). NCoR1 is a conserved physiological modulator of muscle mass and oxidative function. Cell 147, 827-839.
65. Yang R, Wilcox DM, Haasch DL, Jung PM, Nguyen PT, Voorbach MJ, Doktor S, Brodjian S, Bush EN, Lin E, Jacobson PB, Collins CA, Landschulz KT, Trevillyan JM, Rondinone CM & Surowy TK (2007). Liver-specific knockdown of JNK1 up-regulates proliferator-activated receptor γ coactivator 1β and increases plasma triglyceride despite reduced glucose and insulin levels in diet-induced obese mice. J Biol Chem 282, 22765-22774.